ArticleChemistry of materials : a publication of the American Chemical Society2026
Large Colloidal InAs Nanocrystals Synthesized with a Grignard Reagent.
Article in Chemistry of materials : a publication of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colloidal nanocrystals (NCs) active in the near-infrared (NIR) region are appealing for a variety of applications, such as machine vision, hyperspectral imaging, and medical diagnosis. Among the various classes of NIR-active NCs, InAs stands out as one of the most viable compositions in terms of environmental safety. Yet, the synthesis of InAs NCs often relies on expensive and hazardous As precursors, such as tris-(trimethylsilyl)-arsine. Alternative syntheses have also been developed, mainly exploiting tris-(dimethylamino)-arsine (amino-As) in conjunction with a reducing agent (typically organometallic metal hydrides) as a safer and more economical precursor. However, to date, the colloidal synthesis of large InAs NCs (active in the 1000-1600 nm window) using the amino-As route relies on lengthy continuous-injection approaches. In the present study, we demonstrate that using benzyl magnesium chloride (a commercially available Grignard compound) as the reducing agent enables the synthesis of InAs NCs with optical absorption tunable from 835 nm (≈3 nm NC diameter) to 1180 nm (NC diameter of ≈4.2 nm) via a single hot injection procedure. After a ZnSe shell growth, the resulting InAs@ZnSe core@shell NCs exhibit photoluminescence tunable from 1000 to 1500 nm, with photoluminescence quantum yields of 46%, 16%, and 6% at 1030, 1190, and 1500 nm, respectively. We further demonstrate that the synthesis of InAs NCs is compatible with a variety of commercially available Grignard reagents.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.